Larka

Business Impact

Every week, discover in a precise and easy way how your business has been impacted by the recent developments in the bio/pharma industry. Subscribe!

 
Biz_impact_block_website.jpg

White.JPG

9 Jul 18

Big CDMO acquires new analytical capabilities

Blue.JPG

2 Jul 18 Edition

New captive biomanufacturing capacities in Germany

Dark.JPG

25 Jun 18 Edition

New ADC manufacturing site in China soon

White.JPG

18 Jun 18 Edition

US insulin market hits Norwegian Pharma

Dark.JPG

11 Jun 18 Edition

Mid-sized CDMO acquired by PE firm

Blue.JPG

4 Jun 18 Edition

Big Pharma refocuses on core competencies

White.JPG

28 May 18 Edition

French PE firm invests in bio contract manufacturing business

Dark.JPG

21 May 18 Edition

New important fundings for biotechs

White.JPG

14 May 18 Edition

New multi billion USD acquisition

Blue.JPG

7 May 18 Edition

Chinese CDMO opens new bio-manufacturing site in Ireland

White.JPG

30 Apr 18 Edition

CDMO unveils plans to reorganise its Bio business

Blue.JPG

23 Apr 18 Edition

Big strategic changes for Big Pharma

Dark.JPG

16 Apr 18 Edition

World's largest Cell & Gene manufacturing facility opens

White.JPG

9 Apr 18 Edition

New major license agreement in I-O

Dark.JPG

2 Apr 18 Edition

800mn USD acquisitions of cell culture media Cos.

Blue.JPG

26 Mar 18 Edition

GSK pulls out of 20bn USD auction for OTC business

Dark.JPG

19 Mar 18 Edition

Cell & gene contract manufacturing is doing well

White.JPG

12 Mar 18 Edition

New CAR-T biotech created

Blue.JPG

5 Mar 18 Edition

Voluntary worldwide withdrawal of MS drug

Blue.JPG

26 Feb 18

New 150mn USD supply contract for Korean CDMO

Dark.JPG

19 Feb 18 Edition

New bioconjugation method developed for ADCs

White.JPG

12 Fev 18 Edition

Big supply contract for biologics

White.JPG

5 Fev 18 Edition

New multi-billion acquisition

Dark.JPG

29 Jan 18 Edition

Warning Letters also hit Australian CMOs

Blue.JPG

22 Jan 18 Edition

More bio captive capacities coming soon

Blue.JPG

15 Jan 18 Edition

European CDMO is granted a supply agreement in China

Dark.JPG

8 Jan 18 Edition

Newly-approved cell therapy facility for third parties locates in Israel

Blue.JPG

2 Jan 18 Edition

New Warning Letters for Indian sites

White.JPG

25 Dec 17 Edition

Gene therapy manufacturing is taking off

Dark.JPG

18 Dec 17 Edition

South Korea & China on the move

White.JPG

11 Dec 17 Edition

New investments for sterile manufacturing

Blue.JPG

4 Dec 17 Edition

New gene therapy capacity on the market

White.JPG

27 Nov 17 Edition

South Korea well positioned in the biosimilar battle

Dark.JPG

20 Nov 17 Edition

New opportunities for drug delivery service providers

Blue.JPG

13 Nov 17 Edition

More mAb capacity in the US and EU

Dark.JPG

6 Nov 17 Edition

Asia presenting new alternatives for bio manufacturing

White.JPG

30 Oct 17 Edition

Serialisation being handled

Dark.JPG

23 Oct 17 Edition

Generic market in turmoil

Blue.JPG

16 Oct 17 Edition

CMOs buying new sites from Big Pharma

White.JPG

9 Oct 17 Edition

New biomanufaturing capacities emerge

Blue.JPG

2 Oct 17 Edition

Bioconjugation attracts new investments

Diapositive1.JPG

25 Sep 17 Edition

Big CDMO player goes bio